We are live on ! Find out more
NSPR icon

InspireMD

36 hedge funds and large institutions have $34.8M invested in InspireMD in 2025 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 1

21% more capital inflows, than outflows

Capital inflows: $3.5M | Capital outflows: $2.9M

16% more funds holding

Funds holding: 31 → 36 (+5)

0% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 5

5.22% less ownership

Funds ownership: 48.75% → 43.53% (-5.2%)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $9K

Holders
36
Holders Change
+5
Holders Change %
+16.13%
% of All Funds
0.48%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
7
Increased
5
Reduced
5
Closed
1
Calls
–
Puts
$9​K
Net Calls
-⁠$9​K
Net Calls Change
-⁠$10​K

NSPR Hedge Fund Activity: Q1 2025 in Review

36 of the 7,493 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q1 2025, worth a combined $34.8M — up 4% from $33.4M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new NSPR positions and 1 closed out — a net gain of 6 holders — while 5 added to existing stakes and 5 trimmed.

The largest buyer was Nantahala Capital Management, adding an estimated $1.82M. The largest seller was Soleus Capital Management, cutting an estimated $1.22M.

  • 36 institutional investors held InspireMD (NSPR) as of Q1 2025, up from 31 in Q4 2024.
  • Funds reported $34.8M of InspireMD stock for Q1 2025, up 4% quarter-over-quarter.
  • 7 funds opened new InspireMD positions in Q1 2025 and 1 closed out, a net change of +6 holders.
  • The largest InspireMD buyer in Q1 2025 was Nantahala Capital Management, an estimated $1.82M added.
  • The largest InspireMD seller in Q1 2025 was Soleus Capital Management, an estimated $1.22M sold.

Based on aggregated 13F filings for Q1 2025.